These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26065433)

  • 1. A systematic approach to subgroup analyses in a smoking cessation trial.
    Westover AN; Kashner TM; Winhusen TM; Golden RM; Nakonezny PA; Adinoff B; Henley SS
    Am J Drug Alcohol Abuse; 2015; 41(6):498-507. PubMed ID: 26065433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response.
    Nunes EV; Covey LS; Brigham G; Hu MC; Levin FR; Somoza EC; Winhusen TM
    J Clin Psychiatry; 2013 Oct; 74(10):983-90. PubMed ID: 24229749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate.
    Covey LS; Hu MC; Weissman J; Croghan I; Adler L; Winhusen T
    Nicotine Tob Res; 2011 Oct; 13(10):1003-8. PubMed ID: 21652734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.
    Covey LS; Hu MC; Winhusen T; Weissman J; Berlin I; Nunes EV
    Drug Alcohol Depend; 2010 Jul; 110(1-2):156-9. PubMed ID: 20219292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder.
    Covey LS; Hu MC; Winhusen T; Lima J; Berlin I; Nunes E
    J Subst Abuse Treat; 2015 Dec; 59():104-8. PubMed ID: 26272693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.
    Luo SX; Covey LS; Hu MC; Levin FR; Nunes EV; Winhusen TM
    Am J Addict; 2015 Jun; 24(4):348-56. PubMed ID: 25659348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation interventions for smokers with current or past depression.
    van der Meer RM; Willemsen MC; Smit F; Cuijpers P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
    Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME
    Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
    Wolraich ML; Greenhill LL; Pelham W; Swanson J; Wilens T; Palumbo D; Atkins M; McBurnett K; Bukstein O; August G
    Pediatrics; 2001 Oct; 108(4):883-92. PubMed ID: 11581440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.
    Rigotti NA; Gonzales D; Dale LC; Lawrence D; Chang Y;
    Addiction; 2009 Feb; 104(2):266-76. PubMed ID: 19149823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to letter regarding "A systematic approach to subgroup analyses in a smoking cessation trial".
    Henley SS; Kashner TM; Golden RM; Westover AN
    Am J Drug Alcohol Abuse; 2016; 42(1):112-3. PubMed ID: 26717302
    [No Abstract]   [Full Text] [Related]  

  • 19. Tobacco cessation interventions for young people.
    Grimshaw GM; Stanton A
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003289. PubMed ID: 17054164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.